The relationship of the reduced glutathione (GSH) content in unstimulated platelets and their capacity to synthesize thromboxane A2 (TXA2), measured by radioimmunoassay of TXB2, was investigated in diabetic and matched control subjects. The GSH content in platelets from diabetic subjects (6.52 ± 0.73 μg/109 platelets, mean ± SD) was significantly (P < 0.001) lower than in platelets from control subjects (10.10 ± 1.58 μg/109 platelets). When platelet-rich plasma (PRP) was stimulated with 1.65 mM arachidonic acid, significantly (P < 0.001) more TXB2 was formed in PRP from diabetic subjects (344 ± 87 ng/2.5 × 108 platelets) than in PRP from control subjects (132 ± 35 ng/2.5 × 108 platelets). Furthermore, the plasma level of TXB2 was increased in diabetic subjects (522 ±117 pg/ml) in comparison with control subjects (187 ± 63 pg/ml). An inverse correlation (r = 0.98) was observed between the GSH content in unstimulated platelets and their capacity to synthesize TXA2 when stimulated with 1.65 mM arachidonic acid. These data suggest that platelet GSH may have an important regulatory effect on platelet TXA2 synthesis and that increased TXA2 synthesis by platelets from diabetic subjects may be the result of low intracellular GSH levels.
Original Contributions| October 01 1985
Platelet Glutathione and Thromboxane Synthesis in Diabetes
Fred V Lucas;
Address reprint requests to Victor Skrinska, Ph.D., Cleveland Research Institute, 2351 E. 22nd St., Cleveland, Ohio 44115.
George Thomas, Victor Skrinska, Fred V Lucas, O Peter Schumacher; Platelet Glutathione and Thromboxane Synthesis in Diabetes. Diabetes 1 October 1985; 34 (10): 951–954. https://doi.org/10.2337/diab.34.10.951
Download citation file: